and a control group of people who continued use of non-GLP-1 receptor agonist antihyperglycemics, defined as usual care (n = 1,203,097)
Eligibility turns on measurable renal function glomerular filtration rate, serum creatinine, proteinuria, and the urine albumin-to-creatinine ratio plus the absence of acute kidney injury, recent transplant rejection, or active urologic disease
[9],[10] How it works Feiolix is rich in abscisic acid (ABA), a plant compound that naturally triggers GLP-1 release in the gut and feeds beneficial gut bacteria to amplify the effect. [9],[10] What that means for you More natural GLP-1 [9] Lower fasting glucose [9] Reduced triglycerides and LDL [9] Improved gut health and digestion [10] See the clinical studies: Everything else you need to know What is GLP-1 and why does it matter
Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease): systematic review and meta-analysis
These medications have a lower risk of causing gastrointestinal side effects compared to GLP-1 receptor agonists
